ResMed
Is a developer, manufacturer and distributor
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥1,001-5,000
📍San Diego, CA
ResMed

About ResMed

About ResMed
About ResMed
About ResMed
About ResMed
About ResMed
ResMed provides medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

What ResMed is building

ResMed product / service
ResMed product / service
ResMed product / service
ResMed product / service
ResMed product / service
Our cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases.

Technologies used at ResMed

Back-end (3)
Front-end (3)
PythonPython
AWSAWS
LinuxLinux

Company culture

ResPect

ResPect is the employee resource group for our LGBTIQA+ global ResMedians and friends. LGBTIQA+ is an evolving acronym that stands for Lesbian, Gay, Bisexual, Transgender, Intersex, Queer/ Questioning, Asexual and many other terms (such as non-binary and pansexual) that people use to describe their experiences of their gender, sexuality and physiological sex characteristics.

Black Excellence

Recent events have brought to light the continued inequity that exists for People of Colour in our society and by extension for POC professionals in the business world. Our Black Excellence Employee Resource Group was created to give a voice to all POC ResMedians in our businesses across the globe.

See more

Funding rounds

Total Funding

Total Funding

$500M
Last funding round type

Last funding round type

Post-IPO Debt
Company type

Company type

For Profit

ResMed news and updates

ResMed Grows Business Despite Supply Chain Constraints

Facing what its CEO called “a perfect storm” of circumstances, medical device maker ResMed Inc. (NYSE:RMD) concluded its second quarter with net income of $201.8 million, or $1.37 per share, on revenue of $894.9 million. The company’s second quarter ended Dec. 31.

Feb 9, 2022 | San Diego Business Journal

ResMed has issues with recall by competitor Philips of its sleep apnea and ventilator machines

ResMed is seeing increased demand for its respiratory care products thanks to a recall by competitor Philips of its sleep apnea and ventilator machines.

Jan 1, 2022 | medtechdive.com

ResMed launched Airsense 11 CPAP machine on Jan 1st 21'.

ResMed also launched their Airsense 11 CPAP machine in in 2021, which is anticipated to be successful in the US.

Jan 1, 2022 | ht-medicaldevices.com

ResMed launches ResMed Asia and Latin America Sleep Health Survey

ResMed released the results of its ResMed Asia and Latin America Sleep Health Survey, which looked at overall sleep habits and their impact on respondents' well-being across the region.

Jan 1, 2022 | thehansindia.com

ResMed launched AirMini on Apr 1st 17'.

For instance, in April 2017, ResMed launched AirMini, the world’s smallest CPAP machine for the treatment of sleep apnea.

Jan 1, 2022 | thebollywoodticket.com

ResMed acquires Garmin International

ResMed Inc. acquiring MatrixCare and Garmin Ltd collaborating with ActiGraph to diversify their offerings in this product segment.

Jan 1, 2022 | digitaljournal.com

ResMed invested into Curiehealth on Apr 12th 22'.

Curie AI, a tech-enabled respiratory care company that has developed cutting-edge technology for passive respiratory patient monitoring, today announced the closing of a seed round from investors that include ResMed, Factory and SeedToB.

Jan 1, 2022 | businesswire.com

ResMed receives award 2019 MedTech Breakthrough award, “Best Overall Medical Device Product

Brightree’s parent company, ResMed, also won a 2019 MedTech Breakthrough award, “Best Overall Medical Device Product” for the ResMed AirMini, the world’s smallest CPAP machine.

Jan 1, 2022 | homecaremag.com

ResMed Posts Stellar Q1 Results

San Diego-based ResMed (NASDAQ: RMD) posted strong quarterly results last week, beating analysts’ estimates even as ongoing supply chain bottlenecks slowed delivery and sales of the company’s marketing-leading sleep apnea machines and ventilators used to treat COVID patients.

Nov 9, 2021 | San Diego Business Journal

ResMed launches next-generation PAP device

ResMed (NYSE:RMD) has debuted its next-generation positive airway pressure (PAP) device, AirSense 11.

Aug 16, 2021 | Mass Device

New York University files suit against ResMed

New York University has filed a complaint for patent infringement against ResMed.

Jan 1, 2021 | hmenews.com

New York University files suit against ResMed

New York University has filed a complaint for patent infringement against ResMed.

Jan 1, 2021 | hmenews.com

ResMed hires Desney Tan as board of directors

SAN DIEGO – ResMed has elected Desney Tan and John Hernandez, both digital health leaders at leading tech companies, to its board of directors.

Jan 1, 2021 | hmenews.com

ResMed launches update to limited warranty

ResMed announced an update to its limited warranty that may affect whether you choose to use an ozone device with your ResMed machine and mask.

Jan 1, 2020 | esphealthcare.net

ResMed acquired Snapworxllc on Jan 31st 20'.

ResMed ( RMD -3.1% ) subsidiary Brightree has agreed to acquire privately held SnapWorx, LLC, for an undisclosed sum.

Jan 1, 2020 | seekingalpha.com

Morgan Stanley invests into ResMed

Morgan Stanley has invested 0.03% in ResMed Inc. (NYSE:RMD).

Jan 1, 2019 | whatsonthorold.com
See More